Aperio Group LLC raised its stake in National Health Investors, Inc. (NYSE:NHI) by 14.8% during the second quarter, Holdings Channel reports. The institutional investor owned 13,432 shares of the real estate investment trust’s stock after buying an additional 1,736 shares during the period. Aperio Group LLC’s holdings in National Health Investors were worth $1,064,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in NHI. Vanguard Group Inc. boosted its position in shares of National Health Investors by 3.3% in the first quarter. Vanguard Group Inc. now owns 6,219,436 shares of the real estate investment trust’s stock valued at $451,717,000 after buying an additional 201,133 shares in the last quarter. BlackRock Inc. boosted its position in shares of National Health Investors by 6,473.4% in the first quarter. BlackRock Inc. now owns 3,328,567 shares of the real estate investment trust’s stock valued at $241,753,000 after buying an additional 3,277,930 shares in the last quarter. State Street Corp boosted its position in shares of National Health Investors by 8.2% in the first quarter. State Street Corp now owns 920,812 shares of the real estate investment trust’s stock valued at $66,881,000 after buying an additional 69,884 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of National Health Investors by 8.8% in the first quarter. Dimensional Fund Advisors LP now owns 542,845 shares of the real estate investment trust’s stock valued at $39,426,000 after buying an additional 43,890 shares in the last quarter. Finally, Bank of America Corp DE boosted its position in shares of National Health Investors by 2.5% in the first quarter. Bank of America Corp DE now owns 388,780 shares of the real estate investment trust’s stock valued at $28,238,000 after buying an additional 9,538 shares in the last quarter. 69.10% of the stock is currently owned by institutional investors.

Shares of National Health Investors, Inc. (NHI) traded up 2.20% on Wednesday, reaching $79.44. 87,909 shares of the company were exchanged. National Health Investors, Inc. has a 12-month low of $66.31 and a 12-month high of $82.53. The stock has a market capitalization of $3.26 billion, a PE ratio of 20.40 and a beta of 0.56. The firm has a 50 day moving average price of $77.31 and a 200-day moving average price of $75.08.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 EPS for the quarter, missing the Zacks’ consensus estimate of $1.29 by $0.36. The company had revenue of $69.84 million during the quarter, compared to the consensus estimate of $67.68 million. National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. National Health Investors’s quarterly revenue was up 14.1% on a year-over-year basis. During the same period in the previous year, the company earned $1.22 EPS. On average, analysts predict that National Health Investors, Inc. will post $3.79 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, November 10th. Stockholders of record on Friday, September 29th will be issued a $0.95 dividend. This represents a $3.80 dividend on an annualized basis and a dividend yield of 4.89%. The ex-dividend date of this dividend is Thursday, September 28th. National Health Investors’s payout ratio is 97.69%.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by Watch List News and is the property of of Watch List News. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://www.watchlistnews.com/aperio-group-llc-acquires-1736-shares-of-national-health-investors-inc-nhi/1496129.html.

NHI has been the topic of several recent research reports. Zacks Investment Research raised shares of National Health Investors from a “sell” rating to a “hold” rating in a report on Wednesday, August 9th. Mizuho reaffirmed a “neutral” rating on shares of National Health Investors in a report on Wednesday, June 28th. BidaskClub cut shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Saturday, July 8th. Stifel Nicolaus lifted their price objective on shares of National Health Investors from $80.00 to $82.00 and gave the company a “buy” rating in a research note on Wednesday, June 21st. Finally, ValuEngine cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, June 13th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $79.60.

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI).

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.